price up icon2.10%   +1.04
after-market  After Hours:  50.66  0.12   +0.24%

Why is Crinetics Pharmaceuticals Inc (CRNX) Stock down?

We've noticed a 7.16% decline in Crinetics Pharmaceuticals Inc (CRNX) stock during the 2024-04-12 trading session. While this could be attributed to normal volatility or various internal and external factors, please be aware that we are actively monitoring the situation, and we'll provide timely updates as soon as possible!
13 Sep, 2023:

Crinetics Pharmaceuticals (CRNX) shares fell 6.70% after the company announced an offering of 11,441,648 common stock shares at $30.59 each, aiming to raise around $350 million before expenses. The offering includes an option for underwriters to buy an additional 1,716,247 shares. Funds will support research, development, and general corporate purposes, with J.P. Morgan, Morgan Stanley, Leerink Partners, Piper Sandler, and LifeSci Capital managing the offering.


price down icon 1.15%
price up icon 0.32%
price up icon 0.86%
price up icon 2.26%
price up icon 1.98%
price up icon 11.11%
Cap:     |  Volume (24h):